Exotic Naturals ~ E-LL-01

MUMBAI, IndiaExotic Naturals launched a novel research formula E-LL-01, scientifically proven to lower lipid levels and CRP (C-reactive protein), a key indicator for ischemic heart disease. E-LL-01 passes through toughest quality checks of cGMP (current good manufacturing practices) and GACP.

An open-label, randomized study to substantiate the safety and efficacy claims of two doses of E-LL-01 in lowering blood lipids and reducing risk of myocardial infarction was conducted as per ICH-GCP guidelines. A total of 62 patients with low-density lipoprotein (LDL) greater than 160 mg/dl and/or total cholesterol greater than 240 mg/dl were put on E-LL-01 as the sole therapy for 12 weeks. Both the doses of E-LL-01 showed significant reduction (P<0.05) in LDL-C, VLDL-C, triglycerides and total cholesterol at the end of the study as compared to baseline. There was a 34-percent reduction in CRP levels in one of the dose groups indicating reducing the risk of Ischemic heart diseases.